{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:54:15Z","timestamp":1789718055359,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T00:00:00Z","timestamp":1608681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T00:00:00Z","timestamp":1608681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40801-020-00221-8","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T19:02:55Z","timestamp":1608750175000},"page":"49-61","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy"],"prefix":"10.1007","volume":"8","author":[{"given":"Akio","family":"Negishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2638-0550","authenticated-orcid":false,"given":"Shinji","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimitsu","family":"Horii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizue","family":"Mutoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachihiko","family":"Numajiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,23]]},"reference":[{"key":"221_CR1","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s00228-018-2514-5","volume":"74","author":"E S\u00f6nnerstam","year":"2018","unstructured":"S\u00f6nnerstam E, Sj\u00f6lander M, L\u00f6vheim H, Gustafsson M. Clinically relevant drug\u2013drug interactions among elderly people with dementia. Eur J Clin Pharmacol. 2018;74:1351\u201360.","journal-title":"Eur J Clin Pharmacol."},{"key":"221_CR2","doi-asserted-by":"publisher","first-page":"e98043","DOI":"10.1371\/journal.pone.0098043","volume":"9","author":"HA Kim","year":"2014","unstructured":"Kim HA, Shin JY, Kim MH, Park BJ. Prevalence and predictors of polypharmacy among Korean elderly. PLoS ONE. 2014;9:e98043.","journal-title":"PLoS ONE"},{"key":"221_CR3","doi-asserted-by":"publisher","first-page":"e0190102","DOI":"10.1371\/journal.pone.0190102","volume":"12","author":"J Abe","year":"2017","unstructured":"Abe J, Umetsu R, Uranishi H, Suzuki H, Nishibata Y, Kato Y, Ueda N, Sasaoka S, Hatahira H, Motooka Y, Masuta M, Nakamura M. Analysis of polypharmacy effects in older patients using Japanese Adverse Drug Event Report database. PLoS ONE. 2017;12:e0190102.","journal-title":"PLoS ONE"},{"key":"221_CR4","doi-asserted-by":"publisher","first-page":"e010989","DOI":"10.1136\/bmjopen-2015-010989","volume":"6","author":"SS Mortazavi","year":"2016","unstructured":"Mortazavi SS, Shati M, Keshtkar A, Malakouti SK, Bazargan M, Assari S. Defining polypharmacy in the elderly: a systematic review protocol. BMJ Open. 2016;6:e010989.","journal-title":"BMJ Open."},{"key":"221_CR5","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/imj.12203","volume":"43","author":"O Best","year":"2013","unstructured":"Best O, Gnjidic D, Hilmer SN, Naganathan V, McLachlan AJ. Investigating polypharmacy and drug burden index in hospitalised older people. Intern Med J. 2013;43:912\u20138.","journal-title":"Intern Med J."},{"key":"221_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40360-017-0157-2","volume":"18","author":"B Pfister","year":"2017","unstructured":"Pfister B, Jonsson J, Gustafsson M. Drug-related problems and medication reviews among old people with dementia. BMC Pharmacol Toxicol. 2017;18:52.","journal-title":"BMC Pharmacol Toxicol."},{"key":"221_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11606-014-2993-8","volume":"30","author":"W Leiss","year":"2015","unstructured":"Leiss W, M\u00e9an M, Limacher A, Righini M, Jaeger K, Beer HJ, Osterwalder J, Frauchiger B, Matter CM, Kucher N, Angelillo-Scherrer A, Cornuz J, Banyai M, L\u00e4mmle B, Husmann M, Egloff M, Aschwanden M, Rodondi N, Aujesky D. Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism. J Gen Intern Med. 2015;30:17\u201324.","journal-title":"J Gen Intern Med."},{"key":"221_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:230.","journal-title":"BMC Geriatr."},{"key":"221_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afz121","author":"JM Stevenson","year":"2019","unstructured":"Stevenson JM, Davies JG, Martin FC. Medication-related harm: a geriatric syndrome. Age Aging. 2019. https:\/\/doi.org\/10.1093\/ageing\/afz121.","journal-title":"Age Aging."},{"key":"221_CR10","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/bcp.12596","volume":"80","author":"EA Davies","year":"2015","unstructured":"Davies EA, O\u2019Mahony MS. Adverse drug reactions in special populations\u2014the elderly. Br J Clin Pharmacol. 2015;80:796\u2013807.","journal-title":"Br J Clin Pharmacol."},{"key":"221_CR11","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/j.1532-5415.2006.00659.x","volume":"54","author":"M Kuzuya","year":"2006","unstructured":"Kuzuya M, Masuda Y, Hirakawa Y, Iwata M, Enoki H, Hasegawa J, Cheng XW, Iguchi A. Underuse of medications for chronic diseases in the oldest of community-dwelling older frail Japanese. J Am Geriatr Soc. 2006;54:598\u2013605.","journal-title":"J Am Geriatr Soc."},{"key":"221_CR12","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/j.1447-0594.2012.00868.x","volume":"12","author":"T Kojima","year":"2012","unstructured":"Kojima T, Akishita M, Kameyama Y, Yamaguchi K, Yamamoto H, Eto M, Ouchi Y. High risk of adverse drug reactions in elderly patients taking six or more drugs: analysis of inpatient database. Geriatr Gerontol Int. 2012;12:761\u20132.","journal-title":"Geriatr Gerontol Int."},{"key":"221_CR13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1248\/bpb.b16-00930","volume":"40","author":"Y Chisaki","year":"2017","unstructured":"Chisaki Y, Aoji S, Yano Y. Analysis of adverse drug reaction risk in elderly patients using the Japanese Adverse Drug Event Report (JADER) database. Biol Pharm Bull. 2017;40:824\u20139.","journal-title":"Biol Pharm Bull."},{"key":"221_CR14","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1248\/bpb.b15-00253","volume":"38","author":"N Ueda","year":"2015","unstructured":"Ueda N, Umetsu R, Abe J, Kato Y, Nakayama Y, Kato Z, Kinosada Y, Nakamura M. Analysis of neuropsychiatric adverse events in patients treated with oseltamivir in spontaneous adverse event reports. Biol Pharm Bull. 2015;38:1638\u201344.","journal-title":"Biol Pharm Bull."},{"issue":"76","key":"221_CR15","first-page":"1615","volume":"1994","author":"GW Mack","year":"1985","unstructured":"Mack GW, Weseman CA, Langhans GW, Scherzer H, Gillen CM, Nadel ER. Body fluid balance in dehydrated healthy older men: thirst and renal osmoregulation. J Appl Physiol. 1985;1994(76):1615\u201323.","journal-title":"J Appl Physiol"},{"key":"221_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11154-017-9420-5","volume":"18","author":"CA Koch","year":"2017","unstructured":"Koch CA, Fulop T. Clinical aspects of changes in water and sodium homeostasis in the elderly. Rev Endocr Metab Disord. 2017;18:49\u201366.","journal-title":"Rev Endocr Metab Disord."},{"key":"221_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/ki.1976.81","volume":"10","author":"M Miller","year":"1976","unstructured":"Miller M, Moses AM. Drug-induced stated of impaired water excretion. Kidney Int. 1976;10:96\u2013103.","journal-title":"Kidney Int."},{"key":"221_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2147\/CIA.S97481","volume":"11","author":"R Wirth","year":"2016","unstructured":"Wirth R, Dziewas R, Beck AM, Clav\u00e9 P, Hamdy S, Heppner HJ, Langmore S, Leischker AH, Martino R, Pluschinski P, R\u00f6sler A, Shaker R, Warnecke T, Sieber CC, Volkert D. Oropharyngeal dysphagia in older persons\u2014from pathophysiology to adequate intervention: a review and summary of an international expert meeting. Clin Interv Aging. 2016;11:189\u2013208.","journal-title":"Clin Interv Aging."},{"key":"221_CR19","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1016\/j.clnu.2018.11.022","volume":"38","author":"S Tagliaferri","year":"2018","unstructured":"Tagliaferri S, Lauretani F, Pel\u00e1 G, Meschi T, Maggio M. The risk of dysphagia is associated with malnutrition and poor functional outcomes in a large population of outpatient older individuals. Clin Nutr. 2018;38:2684\u20139.","journal-title":"Clin Nutr."},{"key":"221_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1590\/1980-5497201700020013","volume":"20","author":"KG Pereira","year":"2017","unstructured":"Pereira KG, Peres MA, Iop D, Boing AC, Boing AF, Aziz M, d\u2019Orsi E. Polypharmacy among the elderly: a population-based study. Rev Bras Epidemiol. 2017;20:335\u201344.","journal-title":"Rev Bras Epidemiol."},{"key":"221_CR21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1586\/14737167.2016.1115347","volume":"16","author":"V Markovi\u0107-Pekovi\u0107","year":"2016","unstructured":"Markovi\u0107-Pekovi\u0107 V, \u0160krbi\u0107 R, Petrovi\u0107 A, Vlahovi\u0107-Pal\u010devski V, Mrak J, Bennie M, Fadare J, Kwon HY, Schiffers K, Truter I, Godman B. Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future. Expert Rev Pharmacoecon Outcomes Res. 2016;16:609\u201318.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-020-00221-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40801-020-00221-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-020-00221-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T09:48:25Z","timestamp":1616406505000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40801-020-00221-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,23]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["221"],"URL":"https:\/\/doi.org\/10.1007\/s40801-020-00221-8","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,23]]},"assertion":[{"value":"20 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The datasets supporting the conclusions of this article are available in the Pharmaceuticals and Medical Devices Agency repository, .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"AN, NI and DK contributed to the conception and initial design of the manuscript. AN was the major contributor to the design and writing of the manuscript. MM and DK contributed to the final design and writing of the manuscript. SO contributed to the project administration. AN and NH contributed to the data curation, methodology, software and formal analysis. SN and SOh contributed to the review and editing. DK contributed to the conceptualization. All authors read and approved the final manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}